CrushSCI.com
202.7平均天数
205中位天数
61最短天数
393最长天数
4542025发文量

Paper Review Records

全部论文审稿周期

21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

82 天

AI-based prediction of actionable genomic alterations from H&E-stained slides

作者
Woochan Hwang; Fernando Lopez-Rios; Kashif Firozvi; Vivek Subbiah; Siraj M. Ali展开收起
作者单位
1. Department of Medicine, Mount Auburn Hospital, Cambridge, USA; 2. Lunit Inc, Seoul, Republic of Korea; 3. Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i + 12), CIBERONC, Madrid, Spain; 4. Maryland Oncology Hematology, Silver Spring, USA; 5. Division of Oncology, Stanford University School of Medicine, Palo Alto, USA展开收起
PDF源文件 DOI 网页
217 天

Stromal VEGF-C expression predicts nodal metastasis: implications for axillary surgery de-escalation in breast cancer

作者
Pauline Jeannot; Emelie Edvardsson; Oscar Hernquist; Cornelia Brandt; Linnea Fischhaber; Anna-Maria Larsson; Beatrice Öhlund; Kristian Pietras; Pär-Ola Bendahl; Charlotte Rolny; Lisa Ryden展开收起
作者单位
1. Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2. Lund University Cancer Centre, Lund University, Lund, Sweden; 3. Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; 4. SciLifeLab, Department of Laboratory Medicine, Lund University, Lund, Sweden; 5. Department of Gastroenterology and Surgery, Skåne University Hospital, Malmö, Sweden; 6. CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden展开收起
PDF源文件 DOI 网页
61 天

Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics

作者
Mu Li; Lei Zhang; Zhenglun Yu; Jun Li; Shuo Wang; Simeng Zhang展开收起
作者单位
1. Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China; 2. Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, China; 3. Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China; 4. Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China; 5. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China展开收起
PDF源文件 DOI 网页
111 天

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears

作者
Jan-Niklas Eckardt; Chethan Babu V. Reddy; Andrew Srisuwananukorn; Christian Pohlkamp; Maryam Schübel; Ishan Srivastava; Miriam Stoerk; Sebastian Riechert; Tim Schmittmann; Martin M. K. Schneider; Klaus H. Metzeler; Karsten Spiekermann; Markus Badstübner; Susann Winter; Katja Sockel; Frank Kroschinsky; Christoph Röllig; Martin Bornhäuser; Tobias Herold; Torsten Haferlach; Ann-Kathrin Eisfeld; Jan Moritz Middeke展开收起
作者单位
1. Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany; 3. Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 4. Cancilico GmbH, Dresden, Germany; 5. Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA; 6. MLL Munich Leukemia Laboratory, Munich, Germany; 7. Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; 8. Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. National Center for Tumor Diseases (NCT), NCT//UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 11. Department of Hematology, Oncology, and Stem-Cell Transplantation, Munich Hospital Bogenhausen, Munich Municipal Hospital Group, Munich, Germany展开收起
PDF源文件 DOI 网页
393 天

The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology

作者
L. Gräßel; S. Yacob; C. Strantz; E. Prochaska; T. Debertshäuser; AA. Rogge; S. Bäcker; F. Prasser; P. Unberath; J. Wehrle; S. Jäger; M. Boerries; AL Illert; U. Lührig; M. Wolfien展开收起
作者单位
1. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 2. Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3. Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 4. Institute for Medical Informatics and Biometry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Charité - Universitätsmedizin Berlin, Berlin Institute of Health @ Charité, Berlin, Germany; 6. Center for Patient-Centered Outcomes Research, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 7. Department of Psychosomatic Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 8. Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 9. SRH Fürth University of Applied Sciences, Fürth, Germany; 10. Data Integration Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Freiburg, Germany; 11. Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 12. Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; 13. Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI Dresden/Leipzig), Dresden, Saxony, Germany展开收起
PDF源文件 DOI 网页
236 天

An individual sample predictive model to classify patients with metastatic renal cell carcinoma

作者
Anupama Reddy; W. Jared Brewer; Scott M. Haake; Brian Rini展开收起
作者单位
1. Vindhya Data Science, Morrisville, USA; 2. Vanderbilt University Medical Center, Nashville, USA展开收起
PDF源文件 DOI 网页

FAQ

npj Precision Oncology审稿要多久?

截至2026-11-18,CrushSCI 收录了 npj Precision Oncology 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 61 天(Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics,2026-07-04 收稿,2026-09-03 录用),最慢一篇用了 393 天;平均 202.7 天,中位数 205 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。